NO20004668L - 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister - Google Patents
1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonisterInfo
- Publication number
- NO20004668L NO20004668L NO20004668A NO20004668A NO20004668L NO 20004668 L NO20004668 L NO 20004668L NO 20004668 A NO20004668 A NO 20004668A NO 20004668 A NO20004668 A NO 20004668A NO 20004668 L NO20004668 L NO 20004668L
- Authority
- NO
- Norway
- Prior art keywords
- benzylpiperidines
- heteroarylpropyl
- enyl
- prop
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19812331A DE19812331A1 (de) | 1998-03-20 | 1998-03-20 | Piperidinderivate |
PCT/EP1999/001573 WO1999048891A1 (de) | 1998-03-20 | 1999-03-11 | 1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4-benzylpiperidine als nmda-rezeptor-antagonisten |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004668L true NO20004668L (no) | 2000-09-19 |
NO20004668D0 NO20004668D0 (no) | 2000-09-19 |
Family
ID=7861717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004668A NO20004668D0 (no) | 1998-03-20 | 2000-09-19 | 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister |
Country Status (22)
Country | Link |
---|---|
US (1) | US6548516B1 (ja) |
EP (1) | EP1068202B1 (ja) |
JP (1) | JP4451565B2 (ja) |
KR (1) | KR20010042047A (ja) |
CN (1) | CN1123571C (ja) |
AR (1) | AR014747A1 (ja) |
AT (1) | ATE416173T1 (ja) |
AU (1) | AU747900B2 (ja) |
BR (1) | BR9908902A (ja) |
CA (1) | CA2324339C (ja) |
DE (2) | DE19812331A1 (ja) |
DK (1) | DK1068202T3 (ja) |
ES (1) | ES2316184T3 (ja) |
HU (1) | HUP0101220A3 (ja) |
ID (1) | ID26125A (ja) |
NO (1) | NO20004668D0 (ja) |
PL (1) | PL342732A1 (ja) |
PT (1) | PT1068202E (ja) |
RU (1) | RU2217429C2 (ja) |
SK (1) | SK13692000A3 (ja) |
WO (1) | WO1999048891A1 (ja) |
ZA (1) | ZA992191B (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1286975B1 (en) | 2000-05-31 | 2005-08-24 | Warner-Lambert Company LLC | Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
CA2407164A1 (en) | 2000-06-06 | 2001-12-13 | Warner-Lambert Company | Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
JP2004516295A (ja) | 2000-12-21 | 2004-06-03 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | サブタイプ選択的なn−メチル−d−アスパラギン酸拮抗薬としてのピペリジン誘導体 |
MXPA02002749A (es) | 2001-03-27 | 2002-10-28 | Warner Lambert Co | Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato. |
DE10248067A1 (de) * | 2002-10-07 | 2004-04-15 | Proteosys Ag | Heteroarylpropyl-Piperazine und Heteroarylpropyl-Piperidine |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
SG181733A1 (en) | 2009-12-15 | 2012-07-30 | Neurop Inc | Compounds for the treatment of neurologic disorders |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
CN102133198B (zh) * | 2011-03-09 | 2012-02-08 | 北京四环科宝制药有限公司 | 一种酒石酸艾芬地尔冻干粉针剂及其制备方法 |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
CN103965188A (zh) * | 2013-01-29 | 2014-08-06 | 中山大学 | 含硒多奈哌齐类似物 |
CA2984305C (en) * | 2015-04-29 | 2021-12-28 | Janssen Pharmaceutica Nv | Indolone compounds and their use as ampa receptor modulators |
UY36654A (es) | 2015-04-29 | 2016-10-31 | Janssen Pharmaceutica Nv | Azabenzimidazoles con propiedades moduladoras del receptor ampa y composiciones farmacéuticas que los contienen |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
TW281670B (ja) * | 1993-09-02 | 1996-07-21 | Hoffmann La Roche | |
FR2717810B1 (fr) * | 1994-03-22 | 1996-04-26 | Adir | Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
WO1996002250A1 (en) * | 1994-07-20 | 1996-02-01 | Acea Pharmaceuticals Inc. | Haloperidol analogs and the use thereof |
DK0709384T3 (da) * | 1994-10-31 | 1999-08-23 | Merck Patent Gmbh | Benzylpiperidinderivater med høj affinitet til aminosyrereceptorers bindingssteder |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
DE19643790A1 (de) * | 1996-10-30 | 1998-05-07 | Merck Patent Gmbh | Benzoxazol-Derivat |
-
1998
- 1998-03-20 DE DE19812331A patent/DE19812331A1/de not_active Withdrawn
-
1999
- 1999-03-11 JP JP2000537874A patent/JP4451565B2/ja not_active Expired - Fee Related
- 1999-03-11 DE DE59914921T patent/DE59914921D1/de not_active Expired - Lifetime
- 1999-03-11 PT PT99915568T patent/PT1068202E/pt unknown
- 1999-03-11 RU RU2000126475/04A patent/RU2217429C2/ru not_active IP Right Cessation
- 1999-03-11 ID IDW20002091A patent/ID26125A/id unknown
- 1999-03-11 BR BR9908902-5A patent/BR9908902A/pt not_active IP Right Cessation
- 1999-03-11 KR KR1020007010387A patent/KR20010042047A/ko not_active Application Discontinuation
- 1999-03-11 DK DK99915568T patent/DK1068202T3/da active
- 1999-03-11 CA CA002324339A patent/CA2324339C/en not_active Expired - Fee Related
- 1999-03-11 ES ES99915568T patent/ES2316184T3/es not_active Expired - Lifetime
- 1999-03-11 SK SK1369-2000A patent/SK13692000A3/sk unknown
- 1999-03-11 AT AT99915568T patent/ATE416173T1/de not_active IP Right Cessation
- 1999-03-11 AU AU34105/99A patent/AU747900B2/en not_active Ceased
- 1999-03-11 HU HU0101220A patent/HUP0101220A3/hu unknown
- 1999-03-11 WO PCT/EP1999/001573 patent/WO1999048891A1/de not_active Application Discontinuation
- 1999-03-11 US US09/646,185 patent/US6548516B1/en not_active Expired - Fee Related
- 1999-03-11 EP EP99915568A patent/EP1068202B1/de not_active Expired - Lifetime
- 1999-03-11 CN CN99804190A patent/CN1123571C/zh not_active Expired - Fee Related
- 1999-03-11 PL PL99342732A patent/PL342732A1/xx not_active Application Discontinuation
- 1999-03-18 ZA ZA9902191A patent/ZA992191B/xx unknown
- 1999-03-19 AR ARP990101208A patent/AR014747A1/es not_active Application Discontinuation
-
2000
- 2000-09-19 NO NO20004668A patent/NO20004668D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010042047A (ko) | 2001-05-25 |
EP1068202B1 (de) | 2008-12-03 |
EP1068202A1 (de) | 2001-01-17 |
ID26125A (id) | 2000-11-23 |
ZA992191B (en) | 1999-09-29 |
JP4451565B2 (ja) | 2010-04-14 |
HUP0101220A2 (hu) | 2002-05-29 |
HUP0101220A3 (en) | 2003-08-28 |
AU3410599A (en) | 1999-10-18 |
CA2324339A1 (en) | 1999-09-30 |
CN1123571C (zh) | 2003-10-08 |
US6548516B1 (en) | 2003-04-15 |
AR014747A1 (es) | 2001-03-28 |
JP2002507613A (ja) | 2002-03-12 |
DE19812331A1 (de) | 1999-09-23 |
DE59914921D1 (de) | 2009-01-15 |
RU2217429C2 (ru) | 2003-11-27 |
PT1068202E (pt) | 2009-03-06 |
ATE416173T1 (de) | 2008-12-15 |
DK1068202T3 (da) | 2009-03-16 |
CN1293673A (zh) | 2001-05-02 |
WO1999048891A1 (de) | 1999-09-30 |
AU747900B2 (en) | 2002-05-30 |
NO20004668D0 (no) | 2000-09-19 |
BR9908902A (pt) | 2000-11-28 |
SK13692000A3 (sk) | 2001-02-12 |
PL342732A1 (en) | 2001-07-02 |
CA2324339C (en) | 2010-01-12 |
ES2316184T3 (es) | 2009-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004668L (no) | 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister | |
AU2003224064A1 (en) | Substituted indoles | |
CY1108674T1 (el) | Κυκλικα αμιδια | |
HUP0302385A2 (hu) | Új többgyűrűs vegyületek és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
NO20064726L (no) | Imidazolforbindelser for behandling av neurodegenerative forstyrrelser | |
CY1107401T1 (el) | Παραγωγα βενζοθειαζολιου πα την θεραπευτικη αντιμετωπιση της νοσου alzheimer και της νοσου parkinson | |
PT1140945E (pt) | Derivados 1 2 4 tiadiazina fundidos a sua preparacao e a sua utilizacao | |
DE69926254D1 (de) | Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden | |
TW200736255A (en) | 5-(Substituted)-pyrazolopiperidines | |
NO20051689L (no) | Substituerte piperaziner, (1,4) diaszepiner og 2,5-diazabicyklo(2.2.1) heptaner som histamin H1 og/eller H3 antagonister eller histamin H3 revers antagonister | |
NO178262C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler | |
HUT53619A (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same | |
TW200502221A (en) | Novel lactams and uses thereof | |
DE602005023887D1 (de) | Als b-sekretase (bace)-hemmer nützliche 2-amino-chinazolinderivate | |
NO20064989L (no) | Sulfonamidforbindelser for behandling av neurodegenerative lidelser | |
WO1992020649A3 (en) | Substituted 2-carboxyindoles having pharmaceutical activity | |
ATE334965T1 (de) | Piperidinverbindungen als muscarinantagonisten | |
WO2006138355A3 (en) | Effect of bri proteins on abeta production | |
BR0008112A (pt) | Agonistas de 5-ht 1f | |
NO981383L (no) | Benzyloksysubstituerte, kondenserte N-heterocykluser, fremgangsmåter for deres fremstilling og deres anvendelse som bradykininreseptorantagonister | |
ATE524171T1 (de) | Verwendung von 2-(2-nitro-4- trifluormethylbenzoyl)-1,3-cyclohexandion bei der behandlung der parkinson-krankheit | |
NO992063L (no) | Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorer | |
DE69005557D1 (de) | Substituierte 4-Amino-2-butinyl-Harnstoffe und -thioharnstoffe sowie deren Derivate als zentral wirkende muscarinische Mittel. | |
ATE529114T1 (de) | Tetrahydrobenzazepine und ihre verwendung in der modulation des dopamin-d3-rezeptors | |
HUT63626A (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |